Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Determination of salicylamide in pharmaceutical tablets by high-performance thin-layer chromatography with ultraviolet absorption densitometry

Warianty tytułu
Języki publikacji
A new quantitative method using silica gel high-performance thin-layer chromatography (HPTLC) plates with fluorescent indicator, channels, and a concentration zone; instrumental bandwise application of standards and samples; development with dichloromethane–acetone, 4:1, as mobile phase; and ultraviolet absorption densitometry of fluorescence quenched zones is reported for determination of salicylamide in pharmaceutical formulations. The products analyzed to test the applicability of the method were diuretic tablets containing salicylamide, potassium salicylate, and caffeine as active ingredients in unspecified amounts, and extra-strength pain-relief tablets containing salicylamide (152 mg), acetaminophen (110 mg), aspirin (162 mg), and caffeine (32.4 mg). Precision, accuracy, linea-rity, limits of detection and quantitation, and selectivity were validated. Amounts of salicylamide ranged from 2.67 to 2.89 mg in the five diuretic tablets analyzed, and recoveries from five pain-relief tablets ranged from 104.7 to 107.1%. Within-day precision was 0.743% and 0.863% (n = 6) for analysis of the fifth diuretic and fifth pain-relief tablets, respectively. The interday precision was 1.35% and 1.33% (n = 5) for analysis of the fourth diuretic and fourth pain-relief tablets, respectively. Validation of the accuracy of the diuretic tablet results showed the error to be 1.10% for spiked blank analysis, and standard addition analyses gave errors of 1.75% and 0.40% for diuretic and pain-relief tablets, respectively, compared with fortification levels. The limits of detection and quantification were both 2.00 µg, and the correlation coefficient for the salicylamide calibration plot was 0.997 over the range 2.00 to 8.00 µg. The method is suitable for routine quality-control analysis of pharmaceuticals containing salicylamide.
Słowa kluczowe
Opis fizyczny
Bibliogr. 16 poz., rys., tab.
  • Department of Chemistry, Lafayette College, Easton, PA 18042-1782, USA
  • [1] J.V. Aukunuru, U.B. Kompella, and G.V. Betageri, J. Liq. Chromatogr. Related Technol., 23, 565 (2000)
  • [2] J. Patsi, L. Malkki, and S. Tammilehto, Acta Pharm. Nordica, 4, 69 (1992)
  • [3] M.I. Walash, A.M. Elbrashy, and M.A. Sultan, Microchim. Acta, 113, 113 (1994)
  • [4] J.A. Murillo and L.F. Garcia, Anal. Lett., 29, 423 (1996)
  • [5] G. Ragno, G. Ioele, and A. Risoli, Anal. Chim. Acta, 512, 173 (2004)
  • [6] B. Renger, J. AOAC Int., 84, 1217 (2001)
  • [7] B. Renger, J. Planar Chromatogr,. 12, 58 (1999)
  • [8] B. Renger, J. AOAC Int., 81, 333 (1998)
  • [9] The United States Pharmacopeia/The National Formulary (USP24/NF 19). United States Pharmacopeial Convention, Inc., Rockville, MD (2000)
  • [10] Y. Zhu, Chinese J. Med. Ind., 16, 21 (1985)
  • [11] G. Drehsen and P. Rohdewals, J. Chromatogr., 223, 479 (1981)
  • [12] K. Ferenczi-Fodor, Z. Vegh, A. Nagy-Turak, B. Renger, and M. Zeller, J. AOAC Int., 84, 1265 (2001)
  • [13] D. Ruddy and J. Sherma, J. Liq. Chromatogr. Related Technol., 25, 321 (2002)
  • [14] C. Sullivan and J. Sherma, J. AOAC Int., in press
  • [15] C. Sullivan and J. Sherma, J. Liq. Chromatogr. Related Technol., 26, 3453 (2003)
  • [16] J. Sherma and C.D. Rolfe, J. Planar Chromatogr., 5, 197 (1992)
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.